UK markets close in 4 hours 21 minutes
  • FTSE 100

    6,896.81
    +1.52 (+0.02%)
     
  • FTSE 250

    22,213.44
    +127.71 (+0.58%)
     
  • AIM

    1,258.05
    +12.42 (+1.00%)
     
  • GBP/EUR

    1.1538
    -0.0033 (-0.28%)
     
  • GBP/USD

    1.3908
    -0.0024 (-0.17%)
     
  • BTC-GBP

    38,809.48
    -1,189.41 (-2.97%)
     
  • CMC Crypto 200

    1,254.34
    -8.63 (-0.68%)
     
  • S&P 500

    4,173.42
    +38.48 (+0.93%)
     
  • DOW

    34,137.31
    +316.01 (+0.93%)
     
  • CRUDE OIL

    61.02
    -0.33 (-0.54%)
     
  • GOLD FUTURES

    1,783.90
    -9.20 (-0.51%)
     
  • NIKKEI 225

    29,188.17
    +679.62 (+2.38%)
     
  • HANG SENG

    28,755.34
    +133.42 (+0.47%)
     
  • DAX

    15,256.90
    +60.93 (+0.40%)
     
  • CAC 40

    6,249.14
    +38.59 (+0.62%)
     

HSBC and Asian Development Bank join forces in $300 million vaccine financing

·1-min read

LONDON (Reuters) - HSBC and the Asian Development Bank (ADB) will provide a combined $300 million in financing to help Asia's supply chains boost manufacturing capacity for COVID-19 vaccines, the two lenders said on Friday.

The initiative builds on a risk-sharing scheme the banks launched in July to help to fund suppliers of personal protective equipment (PPE) as they and vaccine makers race to meet global demand that outstrips supply.

By leaning on the ADB's sovereign-level credit rating, private sector lenders such as HSBC can lend more easily to companies in the complex chain of vaccine supply production, HSBC said.

"Right now demand for vaccines far outstrips supply and one of the challenges is that supply and distribution networks have to be formed, which requires a lot of liquidity," said Surath Sengupta, global head of financial institutions at HSBC.

The lenders will offer funds through trade loans and invoice financing among other tools, Sengupta said, as countries across Asia try to shorten the usual multi-year time scale needed to deploy large-scale inoculation programmes.

Vaccination levels in Asian countries have varied widely as governments deal with limited supplies, rapidly rising demand and political jockeying to secure doses.

Leaders of the United States, India, Australia and Japan agreed to pool financing, manufacturing and distribution capacity to send 1 billion coronavirus vaccines across Asia by the end of 2022, India's foreign secretary said in March.

(Reporting by Lawrence White; Editing by David Goodman)